Breath I concede the patent examiner issue was a secondary add on that cinched the deal. I still fail to see the logic of a legal standard that uses half cocked science to validate its spur of the moment opinion and have appeals courts then ratify it because some fool made it a bench order. HK
Again, Mori suggests EPA raises LDL. Going by your distinction between anticipation and obvious. The inclination toward strawmans is understandable, but I wouldn't call the appeal on it.
breath, you failed to mention that USPTO used a preponderance of the evidence standard in granting the MARINE patents. Once they are granted, they are presumed to be valid going into Du's court. You seems to be very familiar with the details of Du's ruling. Did the defendants fulfill the burden of clearly and convincingly proving that HTG patients are the same as VHTG patients? If yes, please cite reference. TIA.